Eskander Emphasizes the Importance of Inclusivity and Accessibility in Oncology Clinical Trials

Dr Eskander discusses the impact of social determinants of health on cancer clinical trial participation; effective strategies for considering and engaging diverse communities in the clinical trial process; and how community partnerships can be strengthened to eliminate these financial and logistical barriers.